These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19335063)

  • 1. Nicotinic acetylcholine receptors: an overview on drug discovery.
    D'hoedt D; Bertrand D
    Expert Opin Ther Targets; 2009 Apr; 13(4):395-411. PubMed ID: 19335063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinic acetylcholine receptors as drug targets.
    Hogg RC; Bertrand D
    Curr Drug Targets CNS Neurol Disord; 2004 Apr; 3(2):123-30. PubMed ID: 15078187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The identification of novel structural compound classes exhibiting high affinity for neuronal nicotinic acetylcholine receptors and analgesic efficacy in preclinical models of pain.
    Meyer MD; Decker MW; Rueter LE; Anderson DJ; Dart MJ; Kim KH; Sullivan JP; Williams M
    Eur J Pharmacol; 2000 Mar; 393(1-3):171-7. PubMed ID: 10771011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors.
    Hogg RC; Bertrand D
    Biochem Pharmacol; 2007 Feb; 73(4):459-68. PubMed ID: 16979139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors.
    Wu J; Liu Q; Yu K; Hu J; Kuo YP; Segerberg M; St John PA; Lukas RJ
    J Physiol; 2006 Oct; 576(Pt 1):103-18. PubMed ID: 16825297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
    Riganti L; Matteoni C; Di Angelantonio S; Nistri A; Gaimarri A; Sparatore F; Canu-Boido C; Clementi F; Gotti C
    Br J Pharmacol; 2005 Dec; 146(8):1096-109. PubMed ID: 16273122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relating neuronal nicotinic acetylcholine receptor subtypes defined by subunit composition and channel function.
    Nai Q; McIntosh JM; Margiotta JF
    Mol Pharmacol; 2003 Feb; 63(2):311-24. PubMed ID: 12527802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epibatidine induces long-term potentiation (LTP) via activation of alpha4beta2 nicotinic acetylcholine receptors (nAChRs) in vivo in the intact mouse dentate gyrus: both alpha7 and alpha4beta2 nAChRs essential to nicotinic LTP.
    Matsuyama S; Matsumoto A
    J Pharmacol Sci; 2003 Oct; 93(2):180-7. PubMed ID: 14578586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epibatidine. An old work principle rediscovered].
    Hecker T; Nieber K
    Med Monatsschr Pharm; 1999 Aug; 22(8):226-32. PubMed ID: 10481433
    [No Abstract]   [Full Text] [Related]  

  • 10. Alpha7 nicotinic acetylcholine receptor agonists and positive allosteric modulators.
    Lightfoot AP; Kew JN; Skidmore J
    Prog Med Chem; 2008; 46():131-71. PubMed ID: 18381125
    [No Abstract]   [Full Text] [Related]  

  • 11. Epibatidine and its analogues as nicotinic acetylcholine receptor agonist: an update.
    Yogeeswari P; Sriram D; Ratan Bal T; Thirumurugan R
    Nat Prod Res; 2006 May; 20(5):497-505. PubMed ID: 16644549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of smoking and nicotine in neuropsychiatric disorders: evidence for therapeutic role of nicotinic acetylcholine receptors].
    Miyata H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):149-58. PubMed ID: 18800618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
    Whiteaker P; Sharples CG; Wonnacott S
    Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new look at the neuronal nicotinic acetylcholine receptor pharmacophore.
    Curtis L; Chiodini F; Spang JE; Bertrand S; Patt JT; Westera G; Bertrand D
    Eur J Pharmacol; 2000 Mar; 393(1-3):155-63. PubMed ID: 10771009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The wonderland of neuronal nicotinic acetylcholine receptors.
    Bertrand D; Terry AV
    Biochem Pharmacol; 2018 May; 151():214-225. PubMed ID: 29248596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinic receptor-based therapeutics and candidates for smoking cessation.
    Dwoskin LP; Smith AM; Wooters TE; Zhang Z; Crooks PA; Bardo MT
    Biochem Pharmacol; 2009 Oct; 78(7):732-43. PubMed ID: 19523455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Ca2+ ions in nicotinic facilitation of GABA release in mouse thalamus.
    Léna C; Changeux JP
    J Neurosci; 1997 Jan; 17(2):576-85. PubMed ID: 8987780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in the development of subtype selective nicotinic acetylcholine receptor ligands.
    Astles PC; Baker SR; Boot JR; Broad LM; Dell CP; Keenan M
    Curr Drug Targets CNS Neurol Disord; 2002 Aug; 1(4):337-48. PubMed ID: 12769608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonist and antagonist effects of nicotine on chick neuronal nicotinic receptors are defined by alpha and beta subunits.
    Hussy N; Ballivet M; Bertrand D
    J Neurophysiol; 1994 Sep; 72(3):1317-26. PubMed ID: 7807214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rabbit retinal ganglion cell responses mediated by alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors.
    Reed BT; Amthor FR; Keyser KT
    Vis Neurosci; 2002; 19(4):427-38. PubMed ID: 12511076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.